0001524679-15-000002.txt : 20150624
0001524679-15-000002.hdr.sgml : 20150624
20150624182019
ACCESSION NUMBER: 0001524679-15-000002
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150517
FILED AS OF DATE: 20150624
DATE AS OF CHANGE: 20150624
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Immune Response BioPharma, Inc.
CENTRAL INDEX KEY: 0001524679
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 15950192
BUSINESS ADDRESS:
STREET 1: 244 5TH AVENUE SUITE 1727
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 5407600535
MAIL ADDRESS:
STREET 1: 244 5TH AVENUE SUITE 1727
CITY: NEW YORK
STATE: NY
ZIP: 10001
3
1
primary_doc.xml
PRIMARY DOCUMENT
X0206
3
2015-05-17
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001524679
Immune Response BioPharma, Inc.
244 5TH AVENUE SUITE 1727
NEW YORK
NY
10001
0
0
0
1
Shareholder
PDL Stock
1
D
Initial ownership of PDL one share by Immune Response BioPharma, Inc.
David Buswell
2015-06-24